Video

Higher rates of repeat corneal crosslinking need found in younger patients

Author(s):

David Hutton,Emily Kaiser Maharjan
Conferences|AAO

At AAO 2022, Philip Dockery, MD, MPH, presents, "Effectiveness of corneal crosslinking in young patients."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
Related Content
OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain
July 18th 2025

OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis
July 14th 2025

Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Navigate successful cataract surgery with refractive technology
July 11th 2025

Navigate successful cataract surgery with refractive technology

A look at the vorolanib intravitreal insert compared with aflibercept for DME
July 8th 2025

A look at the vorolanib intravitreal insert compared with aflibercept for DME

© 2025 MJH Life Sciences

All rights reserved.